Ameloblastoma is one of the most common benign tumors of the oral cavity originating from odontogenic epithelium. This tumor is slow-growing but aggressive, locally invasive, has a high potential for recurrence, transforms into malignant and metastasizes. Risk factors such as tumor location, tumor size, patient age, radiographic appearance, a histopathology subtype, and selection of appropriate treatment correlate with recurrence in ameloblastoma. This study aimed to determine the distribution of ameloblastoma based on age, gender, location, and histopathology subtype. This research is quantitative research with a descriptive method using medical record data subjects and paraffin slides/blocks based on predetermined inclusion criteria. Data were grouped by age, gender, location and histopathology subtype. The results are presented in the form of tables and narratives. Based on the data obtained from 27 samples in this study, the age range category of 45-54 years was the age group with the most ameloblastoma found in 11 patients (40.74%). The number of males patients was 13 patients (48.15%) and 14 patients (51.95%) found on females. Most ameloblastomas were found in the mandible, with a total of 26 patients (96.30%). The most common histopathology subtypes were follicular and plexiform histopathology subtypes with 8 patients (29.63%) each.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.